Dannielle Appelhans

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Shawna-Gay White, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dannielle Appelhans:

Company Role Class Num Shares Value Price $ Report Date Ownership
Generation Bio Co. Director Stock Option (right to buy) 30,000 $275,400 $4.59 04 Jun 2025 Direct
Rubius Therapeutics, Inc. CEO and President Restricted Stock Units 22,500 31 Jan 2023 Direct
Rubius Therapeutics, Inc. CEO and President Common Stock 0 24 Feb 2023 Direct

Insider Reports Filed by Dannielle Appelhans

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GBIO Generation Bio Co. 04 Jun 2025 1 $0 4 Director 06 Jun 2025, 16:05
GBIO Generation Bio Co. 06 Jun 2024 1 $0 4 Director 10 Jun 2024, 16:05
GBIO Generation Bio Co. 08 Dec 2023 2 +$14,339 4 Director 11 Dec 2023, 16:30
GBIO Generation Bio Co. 04 Dec 2023 1 +$18,000 4 Director 06 Dec 2023, 16:30
GBIO Generation Bio Co. 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 16:15
/report/000110465923026139-appelhans-dannielle-2023-02-24 Rubius Therapeutics, Inc. 24 Feb 2023 1 -$1,323 4 CEO and President 27 Feb 2023, 17:08
/report/000110465923009464-appelhans-dannielle-2023-01-31 Rubius Therapeutics, Inc. 31 Jan 2023 3 -$970 4 CEO and President 01 Feb 2023, 20:40
/report/000170940122000016-appelhans-dannielle-2022-08-09 Rubius Therapeutics, Inc. 09 Aug 2022 3 -$4,590 4 Chief Operating Officer 12 Aug 2022, 15:06
GBIO Generation Bio Co. 15 Jul 2022 1 $0 4 Director 19 Jul 2022, 16:07
GBIO Generation Bio Co. 15 Jul 2022 0 $0 3 Director 19 Jul 2022, 16:05
/report/000117911022000695-appelhans-dannielle-2022-01-31 Rubius Therapeutics, Inc. 31 Jan 2022 2 $0 4 Chief Operating Officer 01 Feb 2022, 20:19
/report/000117911021008515-appelhans-dannielle-2021-08-31 Rubius Therapeutics, Inc. 31 Aug 2021 2 $0 4 Chief Operating Officer 01 Sep 2021, 20:12
/report/000117911021008205-appelhans-dannielle-2021-08-09 Rubius Therapeutics, Inc. 09 Aug 2021 0 $0 3 Chief Operating Officer 16 Aug 2021, 17:23